RGCC and Personalized Therapies

At Restore + Revive, we are proud to be RGCC-certified, giving us access to advanced molecular diagnostics and therapies. RGCC (Research Genetic Cancer Center) is a leading biotech lab dedicated to advancing personalized cancer care. Their team is driven by a profound commitment to empower people facing cancer with tailored insights that can change the course of their journey. With this certification, our functional medicine providers have access to RGCC’s specialized therapies and the ability to deliver personalized molecular therapies, such as Q-REstrain, to our patients. 

Call 817-720-6220 Ext. 2 or email integrative@restoreandrevivefw.com to learn more or book your consultation.

Who is RGCC?

RGCC, or Research Genetic Cancer Center, is an internationally recognized biotech company specializing in advanced molecular testing and personalized therapy development. Founded in 2004 by genetics pioneer Dr. Ioannis Papasotiriou, RGCC develops precision therapies that certified medical providers can use to support their patients battling cancer and other complex medical conditions. Guided by the belief that patient-specific genetic information is key to effective care, RGCC empowers providers to deliver individualized, data-driven treatments tailored to each patient’s unique needs.

While RGCC is widely recognized for its role in personalized cancer care, its advanced testing also plays a powerful role in prevention. By identifying early molecular changes, immune dysfunction, or chronic infections before symptoms progress, RGCC testing empowers practitioners to create proactive, targeted strategies that support long-term health and disease prevention.

What Does Restore + Revive’s RGCC Certification Mean?

Our RGCC certification signifies that our functional medicine practitioners have completed advanced training in RGCC’s testing processes, genetic analysis, and interpretation of molecular data. This equips our team with advanced diagnostic tools and actionable insights, allowing us to design truly personalized treatment strategies, including Q-REstrain. Only RGCC-certified practitioners are authorized to prescribe and administer Q-REstrain Therapy, ensuring that patients receive it safely and effectively.

With RGCC certification, our providers can:

  • Order and interpret specialized diagnostic panels for cancer, chronic infections, and immune dysfunction.

  • Access individualized therapies developed through RGCC’s proprietary laboratory processes.

  • Collaborate directly with RGCC’s international research team and global network of practitioners, staying at the forefront of personalized care.

These capabilities allow us to move beyond symptom management, offering earlier detection, more precise therapies, and better monitoring, addressing illness at its genetic and molecular roots.

Therapies Made Possible Through RGCC Certification

Because of our RGCC certification, our providers can offer cutting-edge, personalized therapies developed through RGCC laboratories. These therapies are designed to help the body repair and regulate itself at a cellular level. Among these is Q-REstrain, a sophisticated, autologous, non-manipulated therapy that targets the specific genetic sequences driving cancer, viral infections, or Lyme disease, and inhibits their expression.

What is Q-REstrain Therapy?
Q-REstrain Therapy represents one of RGCC’s most advanced innovations in personalized medicine. Using a simple blood sample, RGCC laboratory scientists analyze a patient’s unique genetic markers to create a therapy tailored specifically to their needs. The therapy uses personalized oligonucleotide molecules (small strands of genetic material) to “silence” harmful genes or viral activity at the molecular level. By blocking targeted messenger RNA (mRNA) sequences, Q-REstrain prevents the production of proteins that allow certain cancers, viruses, or infections like Lyme disease to thrive, supporting the body’s natural balance and function.

Q-REstrain Therapy May be Considered for Patients Managing:

  • Certain types of cancer

  • Chronic infections such as Lyme disease, Epstein-Barr Virus (EBV), and other viruses, as well as post-viral fatigue or immune dysregulation

How Q-REstrain Works: The Science and Process

Molecular and Chemical Basis

Q-REstrain Therapy utilizes oligonucleotide molecules, specifically microRNAs isolated from the patient’s own blood sample. These molecules are highly specific for mRNA sequences. By doing so, Q-REstrain “silences” only the problematic genes or viral sequences, preventing the production of proteins that allow cancers, viruses, or infections like Lyme disease to thrive. This precise gene-silencing technology helps restore balance and function at the cellular level.

Delivery and Stability

Each Q-REstrain formulation is fully personalized and stabilized for the individual patient. The therapy is typically administered through injection or intravenous infusion, ensuring efficient absorption and sustained action within the body.

The Process: From Testing to Treatment

Our RGCC-certified R+R practitioners follow a structured process to ensure each patient receives a fully customized therapy.

Monitoring and Follow-Up

We perform ongoing lab assessments to track gene expression, immune markers, or disease activity. These results allow our team to adjust therapy as needed, ensuring optimal outcomes and patient safety.

Who Can Benefit from Q-Restrain?

  • Cancer Support: Personalized sequences can silence oncogenes against tumor cells.

  • Chronic Lyme Disease and Co-Infections: Targets persistent bacterial and viral DNA/RNA to help reduce symptoms and overall pathogen load.

  • Epstein-Barr Virus (EBV): Suppresses latent viral activity to ease fatigue, neurological symptoms, and immune disruption.

  • Emerging Applications: Ongoing research explores use in autoimmune conditions, genetic disorders, and other chronic infections.

FAQs: RGCC and Q-Restrain

Contact

Ready to Learn More About Q-Restrain?

At Restore + Revive, our RGCC-certified team is dedicated to supporting each patient’s unique health needs through personalized, data-driven care. If you’d like to learn more about RGCC and the therapies they offer, we’re here to guide you. 

Call 817-720-6220 Ext. 2 or email integrative@restoreandrevivefw.com to learn more or book your consultation.

You can also visit myrgcc.com for additional information and testimonials.